4-Cyanobutanoic acid, 95.0%, 250mg

Sorafenib>98.0%(HPLC)(T)500mg

(S)-1-Boc-Pyrrolidine-3-carboxylic acid, 97.0%, 5g

1-Isopropyl-2-methyl-piperazine, 95.0%, 5g

Fluazuron, 98%, 250mg

(1S,2S)-N1-(tert-Butoxycarbonyl)-1,2-cyclohexanediamine>98.0%(GC)(T)5g

3-Fluoro-5-nitro-1-trifluoromethylbenzene, 95.0%, 5g

Ethyl 3,4,5-trimethoxybenzoylacetate, 95.0%, 5g

tert-Butyl 7-oxo-5-thia-2-azaspiro[3.4]octane-2-carboxylate, 95%, 5g

4-Nitro-1,3-dihydroisobenzofuran, 95+%, 1g

z-arg(pbf)-oh.cha, 10g

1-Methyl-4-(methylaminomethyl)-1-piperidine, 98.0%, 5g

n-Octylsuccinic anhydride, 98%, 5g